.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent nationwide registry data from Denmark suggests a significant correlation between glucocorticoids and diabetes risk. Glucocorticoids are potent anti-inflammatory agents frequently used across various medical specialties. However, their systemic effects often lead to metabolic complications, including glucose intolerance. This study investigated the dose-response association to determine how prescription intensity impacts the development of Type 2 Diabetes Mellitus (T2DM).
The research analyzed over 149,000 incident T2DM cases matched with controls between 2013 and 2021. Researchers identified a clear progressive increase in the odds of diabetes associated with higher doses of oral systemic glucocorticoids. Specifically, even at a low daily prednisolone-equivalent dose, the adjusted odds ratio (OR) was 1.25. Furthermore, the risk was not exclusive to oral administration; dermatologic applications also showed a positive correlation with incident diabetes.
Moreover, the cumulative dose played a critical role in determining the metabolic outcome. Patients with higher total exposure over a three-year period exhibited a more pronounced risk profile. Consequently, clinicians must evaluate both the duration and the potency of steroid therapy when managing patients with existing metabolic risk factors. Therefore, prioritizing the lowest effective dose for the shortest period is a vital preventive strategy.
These findings underscore the importance of metabolic monitoring for patients requiring steroid therapy. Additionally, healthcare providers should remain vigilant regarding the potential for hyperglycemia even with topical dermatologic treatments. Early screening and lifestyle interventions might mitigate some of the steroid-induced risks. Ultimately, balancing therapeutic benefits against long-term metabolic health remains a cornerstone of prudent clinical practice.
Yes, the Danish registry study indicated that both systemic and dermatologic (topical) glucocorticoid use are associated with increased odds of developing Type 2 Diabetes Mellitus in a dose-dependent manner.
The risk of developing diabetes increases progressively with higher doses of oral systemic glucocorticoids. Even low-dose prescriptions within one year of diagnosis showed a significantly higher risk compared to non-exposed individuals.
Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or to replace the professional judgment of a healthcare provider. Refer to the latest local and national guidelines for clinical practice.
References
Vadsholt D et al. Dose-Response Association Between Systemic and Dermatologic Glucocorticoid Use and Type 2 Diabetes Mellitus: A Nationwide Case-Control Study. Diabetes Obes Metab. 2026 Jun 16. doi: 10.1111/dom.71001. PMID: 42304194.
Chowdhury S, et al. Management of steroid-induced diabetes: A review. Indian J Endocrinol Metab. 2017;21(4):587-594.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A Danish nationwide study involving over 149,000 cases shows that both systemic and dermatologic glucocorticoids are linked to an increased risk of Type 2 Diabetes in a dose-dependent manner.
4 months ago
Depemokimab offers twice-yearly dosing for severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps, significantly cutting exacerbations and hospital admissions.
4 days back
A novel copper metal-organic framework hydrogel remodels the uterine microenvironment to stimulate robust endometrial regeneration, reduce intrauterine fibrosis, and restore reproductive fertility, offering a groundbreaking strategy for managing refractory endometrial damage and Asherman syndrome.
4 days back
New research reveals that non-ablative radiotherapy suppresses ventricular tachycardia by increasing conduction velocity via NaV1.5 upregulation and action potential prolongation. However, sustained sodium current elevation and depressed calcium handling highlight the need for careful clinical translation.
6 days back
A single-cell transcriptomic atlas reveals how peripheral nerve injuries cause dorsal root ganglion remodeling. By evaluating proximal nerve crush and resection, researchers identify distinct glial and immune programs that resolve neuropathic pain and promote regeneration.
4 days back
A breakthrough study demonstrates that fullerol-primed extracellular vesicles generated in a 3D SECCS bioreactor attenuate ferroptosis and restore myogenic regeneration in diabetes via the FOXO3 pathway, offering a cell-free therapeutic strategy for diabetic musculoskeletal degeneration.
4 days back
